Literature DB >> 21327472

Techniques of assessing hypoxia at the bench and bedside.

C E Evans1, K Mattock, J Humphries, P Saha, A Ahmad, M Waltham, A Patel, B Modarai, L Porter, S Premaratne, A Smith.   

Abstract

Tissues require an adequate supply of oxygen in order to maintain normal cell function. Low oxygen tension (hypoxia) is characteristic of a number of conditions, including cancer, atherosclerosis, rheumatoid arthritis, critical limb ischaemia, peripheral vascular disease, and ischaemic heart disease. Tissue hypoxia is found in tumours, atherosclerotic plaque, and ischaemic myocardium. There is a growing interest in methods to detect and assess hypoxia, given that hypoxia is important in the progression of these diseases. Hypoxia can be assessed at the level of the whole organ, tissue, or cell, using both invasive and non-invasive methods, and by a range of immunohistochemical, biochemical, or imaging techniques. This review describes and critiques current methods of assessing hypoxia that are used at the bench and in clinical practice.

Entities:  

Mesh:

Year:  2011        PMID: 21327472     DOI: 10.1007/s10456-011-9205-5

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  3 in total

1.  Repeated assessment of orthotopic glioma pO(2) by multi-site EPR oximetry: a technique with the potential to guide therapeutic optimization by repeated measurements of oxygen.

Authors:  Nadeem Khan; Sriram Mupparaju; Huagang Hou; Benjamin B Williams; Harold Swartz
Journal:  J Neurosci Methods       Date:  2011-11-04       Impact factor: 2.390

2.  Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model.

Authors:  Julio Cárdenas-Rodríguez; Yuguo Li; Jean-Philippe Galons; Heather Cornnell; Robert J Gillies; Mark D Pagel; Amanda F Baker
Journal:  Magn Reson Imaging       Date:  2012-05-01       Impact factor: 2.546

3.  Hypoxia imaging with [18F]HX4 PET in squamous cell head and neck cancers: a pilot study for integration into treatment planning.

Authors:  Helen M Betts; Richard A O'Connor; Judith A Christian; Vidhiya Vinayakamoorthy; Karen Foweraker; Abigail C Pascoe; Alan C Perkins
Journal:  Nucl Med Commun       Date:  2019-01       Impact factor: 1.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.